Friday, December 26, 2025
ADVT 
International

Three students from Telugu states killed in US accident

Darpan News Desk IANS, 26 Oct, 2022 11:58 AM
  • Three students from Telugu states killed in US accident

Hyderabad, Oct 26 (IANS) Three students from Telugu states of Telangana and Andhra Pradesh were killed in a road accident in the US, as per their families.

The casualties occured in a collision between a truck and a mini van in Connecticut state on Tuesday.

According to information reaching the families of the deceased, eight persons were traveling in the mini van. While three persons died on the spot, four others sustained critical injuries while another person received minor injury.

Two of the deceased, including a woman, hail from Telangana while the third victim was from neighbouring Andhra Pradesh.

The deceased were identified as Prem Kumar Reddy (Hyderabad), Pavani (Warangal) and V. Sai Narasimha (East Godavari).

Relatives of Sai Narasimha received the information from his friends that the crash occured between 5 a.m. and 7 a.m. (local time) due to dense fog in the area.

Sai Narasimha, who had gone to the US in August this year, was doing MS. The engineering graduate from Hindustan Engineering College in Chennai was recruited by a company. The 23-year-old later quit the job and enrolled himself for MS in a university in Connecticut.

His parents were shocked on learning about his death. He spoke to them and other family members through a video call to greet them on Diwali.

S. Ishwarya of the same village was lucky to survive the crash with minor injuries.

The families of the deceased have appealed to the governments at the Centre and in the Telugu states to help them in bringing back the bodies.

MORE International ARTICLES

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK

UN: Europe's pandemic restrictions are absolutely necessary

UN: Europe's pandemic restrictions are absolutely necessary
In a meda briefing on Thursday, Dr. Hans Kluge warned that even more drastic steps might be needed in such “unprecedented times.”

UN: Europe's pandemic restrictions are absolutely necessary